Related Experiment Videos
Chronic lymphocytic leukaemia in 5 siblings
Scandinavian Journal of Haematology
|January 1, 1973
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A Systematic Investigation on Barriers and Critical Success Factors for Clinical Information Systems in Integrated Care Settings.
Yearbook of medical informatics·2015
Observing health professionals' workflow patterns for diabetes care - First steps towards an ontology for EHR services.
Studies in health technology and informatics·2015
Structuring clinical workflows for diabetes care: an overview of the OntoHealth approach.
Applied clinical informatics·2014
Anti-H-2 antibodies induced by syngeneic immunization.
Immunogenetics·2012
Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.
Journal of biomedicine & biotechnology·2011
Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).
Scandinavian journal of haematology·1986
The efficacy and toxicity of VAD in the treatment of myeloma and related disorders.
Scandinavian journal of haematology·1986
RES phagocytosis in children with homozygous beta-thalassemia in relation to blood transfusion.
Scandinavian journal of haematology·1986
Two allotypes of factor IX present in haemophilia B.
Scandinavian journal of haematology·1986
Radioimmunoassay of erythropoietin in chronic uraemia or anephric patients.
Scandinavian journal of haematology·1986
Prognostic significance of a morphometric study of lymph node biopsies in chronic lymphocytic leukaemia.
Scandinavian journal of haematology·1986
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026